Inicio › Esquizofrenia › Georgia
Ensayos clínicos de Esquizofrenia en Georgia
28 estudios sobre Esquizofrenia buscan participantes en Georgia.
Ciudades en Georgia
Texto oficial del estudio (inglés)
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
ReclutandoFase 3
Edades de 13 a 17 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07288567A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Atlanta Center for Medical Research, Atlanta
- Local Institution - 0173, Decatur
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- y 1 más
ReclutandoFase 3
Edades de 5 a 17 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07424404Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
ReclutandoFase 3
Edades de 5 a 17 · Todos los sexos · Actualizado el 3 nov 2026 · NCT06229210A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Synexus Clinical Research US Inc, Atlanta
ReclutandoFase 1
Edades de 18 a 60 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07615426Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Emory University., Atlanta
- Avant Psychiatry, Austell
- Local Institution - 0044, Marietta
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07379827Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Local Institution - 0070, Sandy Springs
- Local Institution - 0189, Savannah
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 30 oct 2026 · NCT07686263A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Atlanta
- Clinical Site, Decatur
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 15 oct 2026 · NCT07459647A Study of Brenipatide in Adult Participants With Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Augusta University, Augusta
ReclutandoFase 2
Edades de 18 a 55 · Todos los sexos · Actualizado el 7 oct 2026 · NCT07410507Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Decatur
ReclutandoFase 4
Edades de 12 a 17 · Todos los sexos · Actualizado el 1 oct 2026 · NCT05648591Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07227818NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- y 1 más
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07114874A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CenExel iResearch, LLC, Decatur
ReclutandoFase 1
Edades de 18 a 55 · Todos los sexos · Actualizado el 17 sept 2026 · NCT0773449352-week Open Label Safety-Tolerability Study
- CenExel, Atlanta
- Accelerated Clinical Trial, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07369154A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, LLC, Decatur
ReclutandoFase 1
Edades de 18 a 55 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07061288Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Decatur
ReclutandoFase 3
Edades de 10 a 17 · Todos los sexos · Actualizado el 14 ago 2026 · NCT05303064Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
ReclutandoFase 1
Edades de 10 a 17 · Todos los sexos · Actualizado el 11 ago 2026 · NCT05025605Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CenExel iResearch, Decatur
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 29 jul 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Accelerated Clinical Trial, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07363577Anti-Inflammatory Challenge in Schizophrenia
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
ReclutandoFase 4
Edades de 18 a 55 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05823532CLOZAPINE Response in Biotype-1
- University of Georgia, Athens
ReclutandoFase 4
Edades de 18 a 60 · Todos los sexos · Actualizado el 11 may 2026 · NCT04580134Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- Augusta University Research Institute, Inc., Augusta
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 4 may 2026 · NCT05208190Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
ReclutandoEstudio observacional
Edades de 18 a 40 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- Neurocrine Clinical Site, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 6 mar 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Peachtree Corners
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 12 ene 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5064, Snellville
ReclutandoFase 2
Edades de 21 a 55 · Todos los sexos · Actualizado el 26 dic 2025 · NCT06502964Cognitive Training for Emotion Regulation in Psychotic Disorders
- University of Georgia, Athens
Reclutando
Edades de 18 a 60 · Todos los sexos · Actualizado el 5 feb 2025 · NCT04414215Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Atlanta
- Reviva site, Decatur
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 19 dic 2024 · NCT05184335De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.